Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells to target tumors. TIL therapy, now FDA-approved for solid tumors, shows ...

Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By combining a patient-relevant mouse model with single-cell technologies, the ...

New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?

A research team led by the University of Michigan College of Pharmacy and the University of Texas MD Anderson Cancer Center ...

A Japanese-led research team has developed AUN, a groundbreaking immune-independent bacterial cancer therapy that uses two harmonized bacteria to destroy tumors even in patients with weakened immune ...

A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments.